AHR and leukemia: Furthermore, AhR signaling induces a tolerogenic phenotype in dendritic cells (DCs), diminishing their antigen-presenting capabilities and production of pro-inflammatory cytokines, thereby impairing the initiation of effective anti-leukemia immune responses [102].